Neurology 1998: Vol 50 Index

29 Pages·1998·10.9 MB·English

e:
Subject index to volume 50
A Alexander, Leo
Leo Alexander’s contributions to the Nuremburg Code (Shevell)
Abducens nerve (Historical Neurology) 1998;50:274
A acquJ ired abducens-trigeminal synkinesis (Shulman et al) 1998;50:1507 Alexia
could pure alexia be due to disconnection syndrome? (Mark) (Letter);
increased very long-chain fatty acids in erythrocyte membranes in (Benito—Leén) (Reply) 1998;50:835
patients with aceruloplasminemia (Miyajima et al) 1998;50:130 disruption of residual reading capacity in pure alexic patient after mirror-
Acetazolamide image right hemispheric lesion (Bartolomeo et al) 1998;50:286
acetazolamide-responsive migraine in CADASIL (Weller et al) 1998;50: progressive ventral posterior cortical degeneration presenting as alexia
1505 for music and words (Beversdorf and Heilman) 1998;50:657
Acetylaspartate Alzheimer’s disease
decreased N-acetylaspartate in motor cortex and corticospinal tract in cerebrospinal fluid and plasma insulin levels in Alzheimer’s disease
ALS (Rooney et al) 1998;50:1800 (Craft et al) 1998;50:164
Acetylcholine frontal lobe hypometabolism and depression in Alzheimer’s disease
acetylcholine receptor antibodies in Lambert-Eaton myasthenic (Hirono et al) 1998;50:380
syndrome (Katz et al) 1998;50:470 lack of relation between race and cognitive test performance in
congenital myasthenic syndromes in kinships with endplate Alzheimer’s disease (Carlson et al) 1998;50:1499
acetylcholine receptor and utrophin deficiency (Sieb et al) 1998;50:54 language comprehension and regional cerebral defects in
T-cell recognition of muscle acetylcholine receptor subunits in frontotemporal degeneration and Alzheiiner’s disease (Grossman et
generalized and ocular myasthenia gravis (Wang et al) 1998;50: al) 1998;50:157
1045 object and action naming in Alzheimer’s disease and frontotemporal
Acidosis, lactic dementia (Cappa et al) 1998;50:351
effects of dichloroacetate in patients with MELAS (Saitoh et al) 1998; population study on blood-brain barrier function in 85-year-olds:
50:531 relation to Alzheime;’s disease and vascular dementia (Skoog et al)
mitochondrial tRNA‘ gene mutation in patient with mitochondrial 1998;50:966
myopathy, lactic acidosis, and stroke-like episodes (de Coo et al) preclinical prediction of Alzheimer’s disease using SPECT (Johnson et
1998;50:293 al) 1998;50:1563
Acquired immunodeficiency syndrome; see also Human regional glucose metabolic abnormalities are not result of atrophy in Amo
immunodeficiency virus Alzheimer’s disease (Ibanez et al) 1998;50:1585 re
diagnosis of cytomegalovirus encephalitis in patients with AIDS by relating anatomy to function in Alzheimer’s disease:
quantitation of cyt galovirus gi in cells of cerebrospinal neuropsychological profiles predict regional neuropathology 5 years
fluid (Wildemann et a!) 1998;50:693 later (Kanne et al) 1998;50:979 ce
evaluation and management of intracranial mass lesions in AIDS striatal uptake of dopamine reuptake ligand ["'C]B-CFT is reduced in
(Quality Standards Subcommittee of Amrican Academy of Alzheimer’s disease assessed by positron emission tomography Amy
Neurology) 1988;50:21 (Rinne et al) 1998;50:152 as
human herpesvirus 8 DNA in CNS lymphomas from patients with and sulcal variability in the Alzheimer’s brain correlated with cognition
without AIDS (Corboy et al) 1998;50:335 (Mega et al) 1998;50:145
pathogenesis of diffuse infiltrative lymphocytosis syndrome: an AIDS- Alzheimer’s disease, analysis
related peripheral neuropathy (Berger and Simpson) (Editorial) Alzheimer’s disease assessment scale (Barén et al) (Letter) 1998;50:1516
1998;50:855 drop the Alzheimer’s drop test (Kardon) (Editorial) 1998;50:588
African Americans prevalence and correlates of catastrophic reaction in Alzheimer’s
cognitive test performance among nondemented elderly African disease (Tiberti et al) 1998;50:546
Americans and whites (Manly et al) 1998;50:1238 Alzheimer’s disease, diagnosis
Aged is videopupillography useful in the diagnosis of Alzheimer’s disease?
cognitive function in nondemented older women who took estrogen (Ferrario et al) 1998;50:642
after menopause (Jacobs et al) 1998;50:368 Alzheimer’s disease, etiology
cognitive test performance among nondemented elderly African nonsteroidal anti-inflammatory drug use and Alzheimer-type pathology
Americans and whites (Manly et al) 1998;50:1238 in aging (Mackenzie and Munoz) 1998;50:986
mid-life cardiovascular risk factors, apoE €4, and cognitive decline in Alzheimer’s disease, genetics
elderly male twins (Carmelli et al) 1998;50:1580 earlier onset of Alzheimer’s disease in men with Down syndrome
motor slowing precedes cognitive impairment in oldest old (Camicioli (Schupf et al) 1998;50:991
et al) 1998;50:1496 Alzheimer’s disease, genotype
population study on blood-brain barrier function in 85-year-olds: apolipoprotein E and alpha-1 antichymotrypsin polymorphism
relation to Alzheimer’s disease and vascular dementia (Skoog et al) genotyping in Alzheimer’s disease and in dementia with Lewy
1998;50:966 bodies (Lamb et al) 1998;50:388
Aggression apolipoprotein E genotype influences cognitive ‘phenotype’ in patients
subacute postictal aggression (Gerard et al) 1998;50:384 with Alzheimer’s disease but not in healthy control subjects (Smith
Aging; see also Aged et al) 1998;50:355
earlier onset of Alzheimer’s disease in men with Down syndrome CSF tau is related to apolipoprotein E genotype in early Alzheimer’s
(Schupf et al) 1998;50:991 disease (Tapiola et al) 1998;50:169
estrogen-replacement therapy and Alzheimer’s disease in Italian Alzheimer’s disease, Lewy body
Longitudinal Study on Aging (Baldereschi et al) 1998;50:996 association of CYP2D ahesamaiiee polymorphism with Lewy body
nonsteroidal anti-inflammatory drug use and Alzheimer-type pathology variant of Alzheimer’s disease (Tanaka et al) 1998;50:1556
in aging (Mackenzie and Munoz) 1998;50:986 Alzheimer’s disease, polymorphisms
prevalence of dementia im Chinese elderly in Hong Kong (Chiu et al) association between ACT polymorphism and Alzheimer’s disease
1998;50:1002 (Kamboh et al) (Letter); (Egensperger et al) (Letter); (Miller et al)
white matter changes with normal aging (Guttmann et al) 1998;50:972 (Reply) 1998;50:57
Agraphia, ictal association of CYP2D microsatellite polymorphism with Lewy body
patient study (Schomer et al) 1998;50:542 variant of Alzheimer’s disease (Tanaka et al) 1998;50:1556
Agyria confirmation of association between polymorphism in exon 3 of LRP
agyria-pachygyria and agenesis of corpus callosum: autosomal recessive and Alzheimer’s disease (Hollenbach et al) 1998;50:1905
inheritance with neonatal death (Sztriha et al) 1998;50:1466 Alzheimer’s disease, therapy
AIDS; see Acquired i deficiency syndrome L-deprenyl in Alzheimer’s disease; cognitive and behavioral effects
Albendazole (Freedman et al) 1998;50:660
albendazole therapy for neurocysticercosis (Ko and Chang) (Letter); drugs acting at glycine site on NMDA receptor as cognitive enhancers
(Garcia et al) (Reply) 1998;50:834 in patients with Alzheimer’s disease (Roesler et al) (Letter) 1998;
Albuterol 50:1195
pilot trial of albuterol in fascios¢ p lah al muscular dystrophy enhanced miotic response to topical dilute pilocarpine in patients with
(Kissel et al) 1998;50:1402 Alzheimer’s disease (Kaneyuki et al) 1998;50:802
January issue, pp 1-316; February issue, pp 317-578; February, Supplement 1, pp S1—S48; March issue, pp 579-840; March, Supplement 2, pp S1—S70;
March, Supplement 3, pp S1-S58; April issue, pp 841-1200; April, Supplement 4, pp Al1—A528; May issue, pp 1201-1524; May, Supplement 5, pp S1-S60;
June issue, pp 1525-1972; June, Supplement 6, pp S1-S48.
1944 NEUROLOGY5 0 June 1998
e:
Subject index to volume 50
A Alexander, Leo
Leo Alexander’s contributions to the Nuremburg Code (Shevell)
Abducens nerve (Historical Neurology) 1998;50:274
A acquJ ired abducens-trigeminal synkinesis (Shulman et al) 1998;50:1507 Alexia
could pure alexia be due to disconnection syndrome? (Mark) (Letter);
increased very long-chain fatty acids in erythrocyte membranes in (Benito—Leén) (Reply) 1998;50:835
patients with aceruloplasminemia (Miyajima et al) 1998;50:130 disruption of residual reading capacity in pure alexic patient after mirror-
Acetazolamide image right hemispheric lesion (Bartolomeo et al) 1998;50:286
acetazolamide-responsive migraine in CADASIL (Weller et al) 1998;50: progressive ventral posterior cortical degeneration presenting as alexia
1505 for music and words (Beversdorf and Heilman) 1998;50:657
Acetylaspartate Alzheimer’s disease
decreased N-acetylaspartate in motor cortex and corticospinal tract in cerebrospinal fluid and plasma insulin levels in Alzheimer’s disease
ALS (Rooney et al) 1998;50:1800 (Craft et al) 1998;50:164
Acetylcholine frontal lobe hypometabolism and depression in Alzheimer’s disease
acetylcholine receptor antibodies in Lambert-Eaton myasthenic (Hirono et al) 1998;50:380
syndrome (Katz et al) 1998;50:470 lack of relation between race and cognitive test performance in
congenital myasthenic syndromes in kinships with endplate Alzheimer’s disease (Carlson et al) 1998;50:1499
acetylcholine receptor and utrophin deficiency (Sieb et al) 1998;50:54 language comprehension and regional cerebral defects in
T-cell recognition of muscle acetylcholine receptor subunits in frontotemporal degeneration and Alzheiiner’s disease (Grossman et
generalized and ocular myasthenia gravis (Wang et al) 1998;50: al) 1998;50:157
1045 object and action naming in Alzheimer’s disease and frontotemporal
Acidosis, lactic dementia (Cappa et al) 1998;50:351
effects of dichloroacetate in patients with MELAS (Saitoh et al) 1998; population study on blood-brain barrier function in 85-year-olds:
50:531 relation to Alzheime;’s disease and vascular dementia (Skoog et al)
mitochondrial tRNA‘ gene mutation in patient with mitochondrial 1998;50:966
myopathy, lactic acidosis, and stroke-like episodes (de Coo et al) preclinical prediction of Alzheimer’s disease using SPECT (Johnson et
1998;50:293 al) 1998;50:1563
Acquired immunodeficiency syndrome; see also Human regional glucose metabolic abnormalities are not result of atrophy in Amo
immunodeficiency virus Alzheimer’s disease (Ibanez et al) 1998;50:1585 re
diagnosis of cytomegalovirus encephalitis in patients with AIDS by relating anatomy to function in Alzheimer’s disease:
quantitation of cyt galovirus gi in cells of cerebrospinal neuropsychological profiles predict regional neuropathology 5 years
fluid (Wildemann et a!) 1998;50:693 later (Kanne et al) 1998;50:979 ce
evaluation and management of intracranial mass lesions in AIDS striatal uptake of dopamine reuptake ligand ["'C]B-CFT is reduced in
(Quality Standards Subcommittee of Amrican Academy of Alzheimer’s disease assessed by positron emission tomography Amy
Neurology) 1988;50:21 (Rinne et al) 1998;50:152 as
human herpesvirus 8 DNA in CNS lymphomas from patients with and sulcal variability in the Alzheimer’s brain correlated with cognition
without AIDS (Corboy et al) 1998;50:335 (Mega et al) 1998;50:145
pathogenesis of diffuse infiltrative lymphocytosis syndrome: an AIDS- Alzheimer’s disease, analysis
related peripheral neuropathy (Berger and Simpson) (Editorial) Alzheimer’s disease assessment scale (Barén et al) (Letter) 1998;50:1516
1998;50:855 drop the Alzheimer’s drop test (Kardon) (Editorial) 1998;50:588
African Americans prevalence and correlates of catastrophic reaction in Alzheimer’s
cognitive test performance among nondemented elderly African disease (Tiberti et al) 1998;50:546
Americans and whites (Manly et al) 1998;50:1238 Alzheimer’s disease, diagnosis
Aged is videopupillography useful in the diagnosis of Alzheimer’s disease?
cognitive function in nondemented older women who took estrogen (Ferrario et al) 1998;50:642
after menopause (Jacobs et al) 1998;50:368 Alzheimer’s disease, etiology
cognitive test performance among nondemented elderly African nonsteroidal anti-inflammatory drug use and Alzheimer-type pathology
Americans and whites (Manly et al) 1998;50:1238 in aging (Mackenzie and Munoz) 1998;50:986
mid-life cardiovascular risk factors, apoE €4, and cognitive decline in Alzheimer’s disease, genetics
elderly male twins (Carmelli et al) 1998;50:1580 earlier onset of Alzheimer’s disease in men with Down syndrome
motor slowing precedes cognitive impairment in oldest old (Camicioli (Schupf et al) 1998;50:991
et al) 1998;50:1496 Alzheimer’s disease, genotype
population study on blood-brain barrier function in 85-year-olds: apolipoprotein E and alpha-1 antichymotrypsin polymorphism
relation to Alzheimer’s disease and vascular dementia (Skoog et al) genotyping in Alzheimer’s disease and in dementia with Lewy
1998;50:966 bodies (Lamb et al) 1998;50:388
Aggression apolipoprotein E genotype influences cognitive ‘phenotype’ in patients
subacute postictal aggression (Gerard et al) 1998;50:384 with Alzheimer’s disease but not in healthy control subjects (Smith
Aging; see also Aged et al) 1998;50:355
earlier onset of Alzheimer’s disease in men with Down syndrome CSF tau is related to apolipoprotein E genotype in early Alzheimer’s
(Schupf et al) 1998;50:991 disease (Tapiola et al) 1998;50:169
estrogen-replacement therapy and Alzheimer’s disease in Italian Alzheimer’s disease, Lewy body
Longitudinal Study on Aging (Baldereschi et al) 1998;50:996 association of CYP2D ahesamaiiee polymorphism with Lewy body
nonsteroidal anti-inflammatory drug use and Alzheimer-type pathology variant of Alzheimer’s disease (Tanaka et al) 1998;50:1556
in aging (Mackenzie and Munoz) 1998;50:986 Alzheimer’s disease, polymorphisms
prevalence of dementia im Chinese elderly in Hong Kong (Chiu et al) association between ACT polymorphism and Alzheimer’s disease
1998;50:1002 (Kamboh et al) (Letter); (Egensperger et al) (Letter); (Miller et al)
white matter changes with normal aging (Guttmann et al) 1998;50:972 (Reply) 1998;50:57
Agraphia, ictal association of CYP2D microsatellite polymorphism with Lewy body
patient study (Schomer et al) 1998;50:542 variant of Alzheimer’s disease (Tanaka et al) 1998;50:1556
Agyria confirmation of association between polymorphism in exon 3 of LRP
agyria-pachygyria and agenesis of corpus callosum: autosomal recessive and Alzheimer’s disease (Hollenbach et al) 1998;50:1905
inheritance with neonatal death (Sztriha et al) 1998;50:1466 Alzheimer’s disease, therapy
AIDS; see Acquired i deficiency syndrome L-deprenyl in Alzheimer’s disease; cognitive and behavioral effects
Albendazole (Freedman et al) 1998;50:660
albendazole therapy for neurocysticercosis (Ko and Chang) (Letter); drugs acting at glycine site on NMDA receptor as cognitive enhancers
(Garcia et al) (Reply) 1998;50:834 in patients with Alzheimer’s disease (Roesler et al) (Letter) 1998;
Albuterol 50:1195
pilot trial of albuterol in fascios¢ p lah al muscular dystrophy enhanced miotic response to topical dilute pilocarpine in patients with
(Kissel et al) 1998;50:1402 Alzheimer’s disease (Kaneyuki et al) 1998;50:802
January issue, pp 1-316; February issue, pp 317-578; February, Supplement 1, pp S1—S48; March issue, pp 579-840; March, Supplement 2, pp S1—S70;
March, Supplement 3, pp S1-S58; April issue, pp 841-1200; April, Supplement 4, pp Al1—A528; May issue, pp 1201-1524; May, Supplement 5, pp S1-S60;
June issue, pp 1525-1972; June, Supplement 6, pp S1-S48.
1944 NEUROLOGY5 0 June 1998
estrogen-replacement therapy and Alzheimer’s disease in Italian neuromyotonia, and peripheral neuropathy (Heidenreich and
Longitudinal Study on Aging (Baldereschi et al) 1998;50:996 Vincent) 1998;50:1483
metrifonate benefits cognitive, behavioral, and global function in anticytokine antibodies in beta-interferon-treated patients (Palatucci)
Alzheimer’s disease patients (Morris et al) 1998;50:1222 Letter); (Sibley et al) (Letter); (Pachner) (Reply) 1998;50:1930
metrifonate treatment of cognitive deficits of Aizheime rs disease icidence and significance of neutralizing antibodies to interferon beta-
(Cummings et al) 1998;50:1214 multiple sclerosis (Rudick et al) 1998;50:1266
treatment outcome of tacrine therapy depends on apolipoprotein ) of central nervous system by granulosa cell tumor
genotype and gender of subjects with Alzheimer’s d isease (Farlow immunostained by antibodies against inhibin (Schnittger et al)
1998;50:669 1998:50:560
24-week, double-blind, placebo-controlled trial of donepezil in patients solated internal ophthalmoplegia associated with IgG anti-GQ1b
with Alzheimer’s disease (Rogers et al) 1998;50:136 itibody (Radziwill et al) 1998;50:307
Amaducci, Luigi ise bioassay vs. western blot assay for botulinum toxin antibodies:
Luigi Amaducci MD (1932-1998) (Antuono) (In Memoriam 1998;50 correlation with clinical response (Hanna and Jankovic) 1998;50:
1513
Amantadine nicotinic ACh receptor antibody in subacute autonomic
acute delirium after withdrawal of amantadine in Pa: kinson’s disease ropathy and cancer-related syndromes (Vernino et al) 1998;50:
(Factor et al) 1998;50:1456
amantadine as treatment for dyskinesias and motor fluctuations in meningitis with perinuclear antineutrophil cytoplasmic antibody:
Parkinson’s disease (Verhagen Metman et al) 1998;50:1323 onse to pulse steroid (Takahashi et al) 1998;50:1190
new lessons from old drugs: amantadine and Parkinsor 1S disease astic and oncologic profiles of patients seropositive for type 1
(Goetz) (Editorial; 1998;50:1211 uronal nuclear antibodies (Lucchinetti et al) 1998;50:652
American Academy of Neurology radioimmt inoprecipitation assay for antibodies to botulinum A (Palace
Policy on Conflicts of Interest (Ethics and Humaniti Subcommittee t al) 1998;50:1463
(Position Statement) 1998;50:332 ticardiolipin antibodies in young persons with migraine and
Amnesia tr nsient focal neurologic events (Tietjen et al) 1998;50:1433
impaired recall and preserved encoding in prominent amnesic Antic ardiolipin antibodies
syndrome: a case of basal forebrain amnesia (Fuk atsu et al) 1998; role of anticardiolipin antibodies in young persons with migraine and
50:539 transient focal neurologic events (Tietjen et al) 1998;50:1433
transient autobiographic amnesia etiology (Venneri and Caffarra) hathdamantenmiin
1998;50:186 apolip ein E and alpha-1 antichymotrypsin polymorphism
Amobarbital genc ying in Alzheimer’s disease and in dementia with Lewy
regional cerebral blood flow and language dominance: SPECT during yodies (Lamb et al) 1998;50:388
intracarotid amobarbital testing (McMackin et al) 1998;50:943 Anticoagulation
AMP deaminase early anticoagulation in patients with prosthetic heart valves and
combined defects of muscle phosphofructokinase and AMP deaminase intracerebral hematoma (Leker and Abramsky) 1998;50:1489
in child with myoglobinuria (Bruno et al) 1998;50:296 Antiepileptic drugs
Amyloid EE 0G in antie pileptic drug withdrawal in partial epilepsies (Chabolla)
association of apolipoprotein E €2 and vasculopathy in cerebral r); (Tinuper et al) (Reply) 1998;50:1518
amyloid angiopathy (Greenberg et al) 1998;50:961 ed prospective study of early discontinuation of antiepileptic
Amyotrophic lateral sclerosis rugs in children with epilepsy (Peters et al) 1998;50:724
decreased N-acetylaspartate in motor cortex and cort icospinal tract in Anti-Hu syndrome
ALS (Rooney et al) 1998;50:1800 * association between human leukocyte antigens and anti-Hu
toward earlier diagnosis of amyotrophic lateral sclerosis: revised drome in patients with small-cell lung cancer (Uchuya et al)
criteria (Ross et al) 1998;50:768 1998:50:565
estimation of brainstem neuronal loss in amyotrophic lateral sclerosis Antituberc ulosis drugs
with in vivo proton magnetic resonance spectroscopy (Cwik et al ution of brainstem abscess through antituberculosis therapy
1998;50:72 He 1andez et al) (Letter); (Garcia-Moncé et al) (Reply) 1998;50:
MR imaging in juvenile amyotrophic lateral sclerosis case report 1999
(Midani et al) 1998;50:1879 Aphasia
peripheral insulin-like growth factor system in amyotrophic lateral orrelations of flow velocity changes during mental activity and
sclerosis and multiple sclerosis (Torres—Aleman et al) 1998;50:772 recovery from aphasia in ischemic stroke (Silvestrini et al) 1998;50:
primary hyperparathyroidism and ALS: is there a relation? (Jackson et 191
al) 1998;50:1795 noriat oo asia: syndrome of acute carotid occlusion on dominant
prognostic indicators of survival in amyotrophic lateral sclerosis side (Ghika—Schmid et al) 1998;50:1511
(Stambler) 1998;50:66 Ageligageeteia
quantification of brain metabolites in ALS by localized proton apolipoprotein E and alpha-1 antichymotrypsin polymorphism
magnetic spectroscopy (Ikeda et al) (Letter); Roses ibaum et al) genotyping in Alzheimer’s disease and in dementia with Lewy
(Reply) 1988;50:576 ies (Lamb et al) 1998;50:388 '
riluzole preserves motor function in transgenic mode! of familial oprotein E genotype influences cognitive ‘phenotype’ in patients
amyotrophic lateral sclerosis (Gurney et al) 1998;50:62 with Alzheimer’s disease but not in healthy control subjects (Smith
Aneurysms et al) 1998;50:355
calcium antagonists in patients with aneurysma! subarachnoid association of apolipoprotein E €2 and vasculopathy in cerebral
hemorrhage: a systematic review (Feigin et al) 1998;50:876 amyloid angiopathy (Greenberg et al) 1998;50:961
multiple intracranial and systemic aneurysms associated with tion of association between polymorphism in exon 3 of LRP
infantile-onset arterial fibromuscular dysplasia (Lee et al) 1998;50 and Alzheimer’s disease (Hollenbach et al) 1998;50:1905
828 1 is related to apolipoprotein E genotype in early Alzheimer’s
rapid development of giant fusiform cerebral aneurysms in dise (Tapiola et al) 1998;50:169
angiographically norma! vessels (Johnston et al) 1998;50:1163 -] wie ascular risk factors, apoE €4, and cognitive decline in
Angiography, magnetic r srly male twins (Carmelli et al) 1998;50:1580
spontaneous dural carotid cavernous sinus fistula presenting isolated atment outcome of tacrine therapy depends on apolipoprotein
ophthalmoplegia; evaluation with MR angiography (Uehara et al) genotype and gender of subjects with Alzheimer’s disease (Farlow)
1998;50:814 1998:50:669
Antiarthritic drugs Apomorphine
do antiarthritic drugs decrease risk for cognitive decline? (Prince et al apomorphine responses in Parkinson’s disease and pathogenesis of
1998;50:374 motor complications (Colosimo et al) (Letter); (Verhagen Metman
Antibiotics et al) (Reply) 1988;50:573
fluoroquinolone antibictics block neuromuscular transmission (Sieb) Apraxia
1998;50:804 carbamazepine responsive epileptic oral motor and oculomotor apraxia
Antibodies Naqvi et al) 1998;50:1475
absence of antibodies to non-NMDA glutamate receptor subunits in Aprebetalipoproteinemia
paraneoplastic cerebellar degeneration (Degenhardt et al) 1998;50 neuroacanthocytosis and aprebetalipoproteinemia (Bohlega et al) 1998;
1392 50:1912
acetylcholine receptor antibodies in Lambert-Eaton myasthenic Arteriovenous malformations, spinal
syndrome (Katz et al) 1998;50:470 neurologic manifestations of spinal epidural arteriovenous
antibodies against calcium channel $-subunit in Lambert-Eaton malformations (Hemphill et al) 1998;50:817
myasthenic syndrome (Verschuuren et al) 1998;50:475 Arteritis
antibodies to ion-channel proteins in thymoma with myasthenia, giant cell arteritis and Vernet’s syndrome (Gout et al) 1998;50:1862
June 1998 NEUROLOGY5 0 1945
Arthropathy Child and Adolescent Psychiatry for the Specialty Board Review, edited
neuropathic shoulder arthropathy associated with syringomyelia by Hendren (Williams) 1998;50:1938
(Jones and Wolf) 1998;50:825 Clinical Disorders of Balance, Posture and Gait, edited by Bronstein et
Ataxia al (Leigh) 1998;50:839
delayed diagnosis of Friedrich’s ataxia due to coexisting recessive deaf/ Early Identification of Alzheimer’s Disease and Related Dementias, by
blind syndrome (de Silva et al) 1998;50:1924 U.S. Department of Health and Human Services (Holloway) 1998;
delayed simulation-induced thalamic ataxia syndrome (Hauser et al) 50:1200
1998;50:1184 Handbook of Medical Psychiatry, by Moore and Jefferson (Daroff)
reduced immunoreactivity to calcium-binding proteins in Purkinje cells 1998;50:1199
precedes onset of ataxia in spinocerebellar ataxia-1 transgenic mice Mitochondria & Free Radicals in Neurodegenerative Diseases, edited
(Vig et al) 1998;50:106 by Beal et al (Good) 1998;50:1523
Attention-deficit/hyperactivity disorder Movement Disorders: Neurologic Principles and Practice, by Watts and
cerebellum in attention-deficit/hyperactivity disorder: morphometric Koller (Kieburtz) 1998;50:1199
MRI study (Berquin et al) 1998;50:1087 Myasthenia Gravis, by Oosterhuis (Kaminski) 1998;50:1522
Autonomic nervous system Neuroleptic-Induced Movement Disorders, edited by Yass et al
autonomic dysfunction in Lambert-Eaton myasthenic syndrome (Richard) 1998;50:1199 CA
(O’Suilleabhain et al) 1998;50:88
Neuro-Ophthalmology: Clinical Signs and Symptoms, 4th Edition, by
dissociation between verbal and autonomic measures of memory
Walsh (Katz) 1998;50:1199
following frontal lobe damage (Rapcsak et al) 1998;50:1259 Cal
New Therapeutic Indications of Antidepressants, edited by Mendlewicz
neuronal nicotinic ACh receptor antibody in subacute autonomic
neuropathy and cancer-related syndromes (Vernino et al) 1998;50: et al (Lyness) 1998;50:1938
1806 Optic Nerve Disorders: Ophthalmology Monographs #10, edited by Cal
Autosomal dominant diseases Kline (Katz) 1998;50:840
multiple mtDNA deletions features in autosomal dominant and Polio, edited by Daniel and Robbins (Satran) 1998;50:1522
recessive diseases suggest distinct pathogeneses (Carrozzo et al) Practical Neurology, edited by Biller (Lesser) 1998;50:1938
1998;50:99 Seizures and Epilepsy in Childhood: A Guide for Parents, 2nd Ed., by
rhabdomyolysis in autosomal dominant progressive external Freeman et al (Sehgal) 1998;50:1522
ophthalmoplegia (Melberg et al) 1998;50:299 Subarachnoid Hemorrhage: Medical and Surgical Management, edited
Autosomal recessive diseases by Yanagihara et al (Lanska) 1998;50:1523
agyria-pachygyria and agenesis of corpus callosum: autosomal Botulinum toxin Cal
recessive inheritance with neonatal death (Sztriha et al) 1998;50: long-term effect of botulinum toxin on impairment and functional
1466 health in cervical dystonia (Brans et ai) 1998;50:1461
genetic heterogeneity in autosomal recessive hereditary motor and mouse bioassay vs. Western blot assay for botulinum toxin antibodies: Ca
sensory neuropathy with focally folded myelin sheaths correlation with clinical response (Hanna and Jankovic) 1998;50: Ca
(Gambardella et al) 1998;50:799 1624 Ca
multiple mtDNA deletions features in autosomal dominant and radioimmunoprecipitation assay for antibodies to botulinum A (Palace
recessive diseases suggest distinct pathogeneses (Carrozzo et al) et al) 1998;50:1463
1998;50:99 Brachial plexopathies Cai
Azathioprine cervical rib and median sternotomy-related brachial plexopathies
randomized double-blind trial of prednisolone alone or with (Levin et al) 1998;50:1407
azathioprine in myasthenia gravis (Palace et al) 1998;50:1778 Brain; see also specific regions of brain
arterial territories of human brain: cerebral hemispheres (Tatu et al) Ca
B 1998;50:1699
Baltimore-Washington Cooperative Young Stroke Study brain-behavior correlations in hemispatial neglect using CT and
cerebral infarction in young adults: Baltimore—Washington SPECT; The Sunnybrook Stroke Study (Leobovitch et al) 1998;50: Ca
Cooperative Young Stroke Study (Kittner et al) 1998;50:890 901
illicit drug-associated ischemic stroke in Baltimore—Washington brain size, head size, and IQ in monozygotic twins (Tramo et al) 1998;
Cooperative Young Stroke Study (Sloan et al) 1998;50:1688 50:1246
Basal ganglia effect of training and different measurement strategies on
calcification in basal ganglia with chronic active Epstein-Barr virus reproducibility of brain MRI lesion load measurements in multiple
infection (Morita et al) 1998;50:1485 sclerosis (Filippe et al) 1998;50:238
Behavior lacunes due to dilatations of perivascular spaces (Poirier) (Letter)
behavioral neurology of cerebral white matter (Filley) (Views & 1998;50:1193
Reviews) 1998;50:1535 population study on blood-brain barrier function in 85-year-olds:
brain-behavior correlations in hemispatial neglect using CT and relation to Alzheimer’s disease and vascular dementia (Skoog et al)
SPECT; The Sunnybrook Stroke Study (Leobovitch et al) 1998;50: 1998;50:966
901 quantification of brain metabolites in ALS by localized proton
L-depreny! in Alzheimer’s disease; cognitive and behavioral effects magnetic spectroscopy (Ikeda et al) (Letter): (Rosenbaum et al)
(Freedman et al) 1998;50:660 (Reply) 1988;50:576
metrifonate benefits cognitive, behavioral, and global function in status epilepticus increases CSF levels of neuron-specific enolase and
Alzheimer’s disease patients (Morris et al) 1998;50:1222 alters blood-brain barrier (Correale et al) 1998;50:1388 Ca
Biochemical markers temporal !obe epilepsy in genius of natural history; MRI volumetric
cytologically negative carcinomatous meningitis: usefulness of CSF study of postmortem brain (Murai et al) 1998;50:1373
biochemical markers (Chamberlain) 1998;50:1173 white matter changes with normal aging (Guttmann et al) 1998;50:972
Blood-brain barrier Brainstem Ce
population study on blood—brain barrier function in 85-year-olds: brainstem and thalamic lesions in dentatorubral-pallidoluysian
relation to Alzheimer’s disease and vascular dementia (Skoog et al) atrophy: MRI study (Tomiyasu et al) 1998;50:1887 Ce
1998;50:966
estimation of brainstem neuronal loss in amyotrophic lateral sclerosis
status epilepticus increases CSF levels of neuron-specific enolase and
with in vivo proton magnetic resonance spectroscopy (Cwik et al)
Blood palrtoedrsu cbtlso od-brain barrier (Correale et al) 1998;50:1388 1998;50:72 Ce
Creutzfeldt-Jakob disease after blood product transfusion for donor proton spectroscopy in narcoleptic syndrome: is there evidence of a
with CJD (Patry et al) 1998;50:1872 brainstem lesion? (Ellis et al) 1998;50:S23 (Feb, suppl 1)
Boneea rlmya rnreuorwo lotgirca nscopmlpalnitcaattiioonns following allogenic bone marrow resol(uHteironn anodfe bzr aeitn satl)e m( Leatbtsecre);s s (tGharrocuigah- Moannctéi tuebte raclu) lo(sRiesp lyt)h e1r9a9p8y; 50: Ce
transplant for leukemia (Antonini et al) 1998;50:1441 1929
Book reviews Breast cancer
Advances in Neurology, Volume 70, Supplementary Sensorimotor Area, stiff-man syndrome in breast cancer (Rosin et al) 1998;50:94
edited by Luders (Blum and Drislane) 1998;50:839 Breast implants
Amyotrophic Lateral Sclerosis: Diagnosis and Management for the breast implants and risk of neurologic disease: population-based cohort Ce
Clinician, edited by Belsh and Schiffman (Armon) 1998;50:1523 study in Sweden (Nyrén et al) 1998;50:956
Brain Imaging in Clinical Psychiatry, edited by Krishnan and breast implants redux: this time with data (Ferguson) 1998;50:849
Doraiswamy (Aylward) 1998;50:1939 neurologic disease among women with breast implants (Winther) 1998;
Brain Imaging in Psychiatry, by Lewis and Higgins (Aylward) 1998;50: 50:951
840 Breast milk
Central Nervous System Infectious Diseases and Therapy, edited by levodopa in human breast milk: clinical implications (Thulin et al)
Roos (Booss) 1998;50:1200 (see erratum, 1998;50:1943) 1998;50:1920
1946 NEUROLOGY 50 June 1998
Britain Cerebral angiopathy
absence of G209A mutation in a-synuclein gene in British families ssociation of apolipoprotein E €2 and vasculopathy in cerebral
with Parkinson's disease (Bennett and Nicholl) 1998;50:1183 myloid angiopathy (Greenberg et al) 1998;50:961
Bulbar palsy postpartum cerebral angiopathy with intracerebrai hemorrhage in
Wegener's granulomatosis presenting with bulbar p:y alsy and bilateral patient receiving lisuride (Roh and Park) 1998;50:1152
jugular vein compression (Hadden et a!) 1998;50:1923 Cerebral artery disease
middle cerebral artery main stem thrombosis in siblings with familial
rombotiec thrombocytopenic purpura (Kelly et al) 1998;50:1157
C rapid deve lopment of giant fusiform cerebral aneurysms in
CADASIL giographically normal vessels (Johnston et al) 1998;50:1163
acetazolamide-responsive migraine in CADASIL (Weller et al 1998:50 Cerebral blood flow
1505 global cerebral blood flow, blood volume, and oxygen metabolism in
SPECT study of German CADASIL family: phenotype with migraine patients with migraine headache (Bednarczyk et al) 1998;50:1736
and progressive dementia (Mellies et al) 1998;50:1715 ninvasive MRI evaluation of cerebral blood flow in cerebrovascular
CAG repeats disease (Detre et al) 1998;50:633
'"H NMR spectroscopy studies of Huntington’s disease: correlations gional cerebral blood flow and language dominance: SPECT during
with CAG repeat numbers (Jenkins et al) 1998;50:1357 ntracarotid amobarbital testing (McMackin et al) 1998;50:943
Calcification Cerebral blood volume
calcification in basal ganglia with chronic active Epstein-Barr virus global cerebral blood flow, blood volume, and oxygen metabolism in
infection (Morita et al) 1998;50:1485 patients with migraine headache (Bednarczyk et al) 1998;50:1736
Calcium nereased CBV in HIV+ subjects detected by functional MRI (Tracey et
antibodies against calcium channel! $-subunit in Lambert-Eaton 1998:50:1821
myasthenic syndrome (Verschuuren et al) 1998;50:475 Cerebral cortex
reduced immunoreactivity to calcium-binding proteins in Purkinje cells abnormal! cortical development and epileptogenesis at epilepsy surgery
precedes onset of ataxia in spinocerebellar ataxia-1 transgenic mice tula) 1998;50:8
(Vig et al) 1998;50:106 ehavioral neurology of cerebral white matter (Filley) (Views &
variable clinical expression of mutations in P/Q-type calc “ium channel Re ) 1998;50:1535
gene in familial hemiplegic migraine Terwindt et al) 1998;50:1105 I ytochemical study of cortical dysplasia (Spreafico et al) 1998;
Calcium antagonists
calcium antagonists in patients with aneurysmal! subar achnoid metabolic dysfunction in patients with cortical developmental
hemorrhage: a systematic review (Feigin et al) 1998;50:876 formations: proton magnetic resonance imaging study (Li et al)
Cancer; see specific neoplastic diseases 998:50:755
Cancer; see Neoplasms Cerebral defects
Carbamazepine guage comprehension and regional cerebral defects in
carbamazepine responsive epileptic oral motor and oculomotor apraxia totemporal degeneration and Alzheimer’s disease (Grossman et
(Naqvi et al) 1998;50:1475 1998:50:157
Cardiac arrest Cerebral hematoma
cerebrospinal fluid creatine kinase BB isoenzyme activity and ea icoagulation in patients with prosthetic heart valves and
neurologic prognosis after cardiac arrest (Toms and Frank acerebral hematoma (Leker and Abramsky) 1998;50:1489
(Letter); (Tirschwell and Longstreth) (Reply) 1998;50:830 Cere sr al hemispheres
Cardiac tamponade irterial territories of human brain: cerebral hemispheres (Tatu et al)
hemopericardium and cardiac tamponade after thrombolysis for acute 1998:50:1699
ischemic stroke (Kasner et al) 1998;50:1857 Cerebral hemorrhage
Cardiovascular disorders; see also specific disorder Ss n of Ginkgo biloba with intracerebral hemorrhage
cardiac cephalgia (Gilbert) (Letter); (Lipton and Newman 1998;50:836 Matthews) (Letter); (Lewis and Rowin) (Reply) 1998;50:1933
ischemic stroke: outcomes, patient mix, and practice ation for I sparganosis with intracerebral hemorrhage (Jeong et al) 1998;
neurologists and generalists in community (Pett al) 1998;50
1669 hes in intracerebral hemorrhage survivors (Ferro et al) 1998;50:
midlife cardiovascular risk factors, apoE «4, and cognitive decline in
elderly male twins (Carmelli et al) 1998;50:158\ stpartum cerebral angiopathy with intracerebral hemorrhage in
Carotid artery diseases t receiving lisuride (Roh and Park) 1998;50:1152
bilateral optic disk pallor after unilateral internal! carotid artery nse to external ventricular drainage in spontaneous intracerebral
occlusion (Archer et al) 1998;50:809 I ,age with hydrocephalus (Adams and Diringer) 1998;50:519
brief, transient Horner’s syndrome can be halimar} rotid artery Cerebrz r infarction
dissection (Leira et al) 1998;50:289 farction in young adults: Baltimore-Washington
does the neurologist add value to the carotid endar ectomy patient rative Young Stroke Study (Kittner et al) 1998;50:890
(Chaturvedi and Hachinski) (Views & Reviews 1998:50:610 screening examinations for silent cerebral infarcts in sickle
moriatic aphasia: syndrome of acute carotid occlusion on dominant disease (DeBaun et al) 1998;50:1678
side (Ghika—Schmid et al) 1998;50:1511 farcts in middle cerebral artery territory, etiology and outcome
Cavernous sinus rns (Heinsius et al) 1998;50:341
spontaneous dural carotid cavernous sinus fistula presenting isolated ind recurrence after first cerebral infarction (Petty et al)
ophthalmoplegia; evaluation with MR angio Uehara et al 998:50:208
1998;50:814 Cerebral sparganosis
Cefuroxime sparganosis with intracerebral hemorrhage (Jeong et al) 1998;
cefuroxime-induced encephalopathy (Herishanu et 1998;50:1873
Celiac disease Cerebral re
chronic progressive leukoencephalopathy in adult celiac disease rebral vasculitis during FK506 treatment in liver transplant patient
(Beyenburg et al) 1998;50:820 izzolato et al) 1998;50:1154
Cell adhesion molecules Cerebrospinal fluid
effects of intravenous methylprednisolone therapy on leukocyte and pha tocopherol in CSF of subjects taking high-dose vitamin E in
soluble adhesion molecule expression in multiple sclerosis (Droogan DATATOP study (Vatassery et al) 1998;50:1900
et al) 1998;50:224 spinal fluid and plasma insulin levels in Alzheimer’s disease
Cerebellar degeneration Craft et al) 1998;50:164
absence of antibodies to non-NMDA glutamate-receptor subunits in ebrospina! fluid creatine kinase BB isoenzyme activity and
paraneoplastic cerebellar degeneration (Degenhardt et al) 1998;50 rologic prognosis after cardiac arrest (Toms and Frank)
1392 Letter : (Tirschwell and Longstreth) (Reply) 1998;50:830
cerebellar degeneration associated with human imm unodeficiency CSF levels of carnitine in children with meningitis, neurological
virus infection (Tagliati et al) 1998;50:244 lisorders, acute gastroenteritis and seizures (Shinawi et al) 1998;
Cerebellum 50:1869
cerebellum in attention-deficit/hyperactivity disorder morphometric SF neurofilament and glial fibrillary acidic protein in normal
MRI study (Berquin et al) 1998;50:1087 yressure hydrocephalus (Tullberg et al) 1998;50:1122
congenital muscular dystrophy and cerebellar atrophy (Echenne et al 1 is related to apolipoprotein E genotype in early Alzheimer’s
1998;50:1477 ease (Tapiola et al) 1998;50:169
decreased cerebellar posterior vermis size in fragile X syndrome tologically negative carcinomatous meningitis: usefulness of CSF
correlated with neurocognitive performance (Mostofsky et al) 1998 biochemical markers (Chamberlain) 1998;50:1173
50:121 diagnosis of cytomegalovirus encephalitis in patients with AIDS by
June 1998 NEUROLOGY 50 1947
:
qfluuaindt i(tWaitilodne maofn nc yteotm ealg)a l1o9v9i8r;u5s0 :6g9e3n omes in cells of cerebrospinal Charmcyoetl-iMna rpireo-tTeoino thz erod isgeeansee (tMyapre ro2s ua sseotc iaalt)e d1 99w8i;th5 0:m1u3t9a7t ion of || Clin
‘11 [ndium-diethylenetriamine pentaacetic acid cerebrospinal fluid flow Charcot-Marie-Tooth disease type 1A with 17p duplication in infancy |
studies predict distribution of intrathecally administered and early childhood: longitudinal clinical and electrophysiologic Clin
chemotherapy and outcome in patients with leptomeningeal study (Garcia et al) 1998;50:1061
metastases (Mason et al) 1998;50:438 PCR-based strategy for diagnosis of hereditary neuropathy with
matrix metalloproteinase 9 in cerebrospinal fluid of HTLV-1 infected liability to pressure palsies and Charcot-Marie-Tooth disease type
patients with tropical spastic paraparesis (Giraudon et al) 1998;50: 1A (Young et al) 1998;50:760
1920 X-linked Charcot-Marie-Tooth disease with connexin 32 mutations;
optic neuritis: prognosis for multiple sclerosis from MRI, CSF, and clinical and electrophysiologic study (Birouk et al) 1998;50:1074
HLA findings (Séderstrom et al) 1998;50:708 Chemotherapy; see also specific drugs and drug types
tumor necrosis factor-a, interleukin-18, and interleukin-6 in assessing response to chemotherapy in malignant glioma: role of
cerebrospinal fluid from children with prolonged febrile seizures steroids (Weller) (Letter); (Hess et al) (Reply) 1998;50:1196 Coc:
compared with acute encephalitis/encephalopathy (Ichiyama et al) 111Indium-diethylenetriamine pentaacetic acid cerebrospinal fluid flow
1998;50:407 studies predict distribution of intrathecally administered
upper cervical myelopathy associated with low CSF pressure: chemotherapy and outcome in patients with leptomeningeal Cog
complication of V-P shunt (Miyazaki et al) 1998;50:1864 metastases (Mason et al) 1998;50:438
Cerebrovascular disorders Children
central poststroke pain and Wallenberg’s lateral medullary infarction agyria-pachygyria and agenesis of corpus callosum: autosomal
(Bowsher) (Letter); (Leijon) (Letter); (MacGowan et al) (Reply) recessive inheritance with neonatal death (Sztriha et al) 1998;50:
1998;50:1520 1466
central poststroke pain associated with lateral medullary infarction antibodies against human putamen in children with Tourette
(Silverman) (Letter); (MacGowan et al) (Reply) 1998;50:836 syndrome (Singer et al) 1998;50:1618
correlation of perfusion- and diffusion-weighted MRI with NIHSS score Charcot-Marie-Tooth disease type 1A with 17p duplication in infancy
in acute ischemic stroke (Tong et al) 1998;50:864 and early childhood: longitudinal clinical and electrophysiologic
dolichoectasia of intracranial arteries in patients with first ischemic study (Garcia et al) 1998;50:1061
stroke: population-based study (Ince et al) 1998;50:1694 childhood headache at school entry: controlled clinical study (Aromaa
illicit drug-associated ischemic stroke in Baltimore—Washington Young et al) 1998;50:1729
Stroke Study (Sloan et al) 1998;50:1688 childhood narcolepsy (Wise) 1998;50:S37 (Feb, suppl 1)
intracranial stenosis in Chinese patients with acute stroke (Wong et childhood onset of benign positional vertigo (Baloh and Honrubia)
al) 1998;50:812 1998;50:1491
ischemic stroke after surgical procedures: clinical features, combined defects of muscle phosphofructokinase and AMP deaminase
neuroimaging, and risk factors (Limburg et al) 1998;50:895 in child with myoglobinuria (Bruno et al) 1998;50:296
is in-hospital stroke mortality an accurate measure of quality of care? CSF levels of carnitine in children with meningitis, neurological
(Hinchley et al) 1998;50:619 disorders, acute gastroenteritis and seizures (Shinawi et al) 1998;
magnetic resonance imaging in acute stroke: not ready for prime time 50:1869
(Powers and Zivin) (Editorial) 1998;50:842 early onset parkinsonism with diurnal fluctuation maps to locus for
persistent inflammatory response in stroke survivors (Beamer et al) juvenile parkinsonism (Matsumine et al) 1998;50:1340
1998;50:1722 epilepsy diagnosis and localization in patients with antecedent
pneumatic sequential compression reduces risk of deep vein
childhood febrile convulsions (Hamati-Haddad and Abou—Khalil)
thrombosis in stroke patients (Kamran et al) 1998;50:1683 1998;50:917
Cerebrovascular disorders, etiology
MR imaging in juvenile amyotrophic lateral sclerosis: case report
recent bacterial and viral infection is risk factor for cerebrovascular
(Midani et al) 1998;50:1879
ischemia (Grau et al) 1998;50:196
multiple intracranial and systemic aneurysms associated with
Cerebrovascular disorders, pathology
infantile-onset arterial fibromuscular dysplasia (Lee et al) 1998;50:
correlations of flow velocity changes during mental activity and
828
recovery from aphasia in ischemic stroke (Silvestrini et al) 1998;50:
randomized prospective study of early discontinuation of antiepileptic
191
drugs in children with epilepsy (Peters et al) 1998;50:724
mitochondrial tRNA‘! gene mutation in patient with mitochondrial
rhabdomyolysis and hypoxia associated with prolonged propofol
myopathy, lactic acidosis, and stroke-like episodes (de Coo et al)
1998;50:293 infusion in children (Hanna and Ramundo) 1998;50:301
Cerebrovascular disorders, therapy tumor necrosis factor-a, interleukin-18, and interleukin-6 in
cost-effectiveness of tissue plasminogen activator for acute ischemic cerebrospinal fluid from children with prolonged febrile seizures
stroke (Fagan et al) 1998;50:883 compared with acute encephalitis/encephalopathy (Ichiyama et al)
effects of dichloroacetate in patients with MELAS (Saitoh et al) 1998; 1998;50:407
50:531 China
efficacy of prourokinase in embolic stroke model evaluated by intracranial stenosis in Chinese patients with acute stroke (Wong et
diffusion-perfusion magnetic resonance imaging (Takano et al) al) 1998;50:812
1998;50:870 prevalence of dementia in Chinese elderly in Hong Kong (Chiu et al)
factors determining therapeutic window for stroke (Zivin) (Views & 1998;50:1002
Reviews) 1998;50:599 Chlamydia pneumoniae
hemopericardium and cardiac tamponade after thrombolysis for acute multiple sclerosis associated with Chlamydia pneumoniae infection of
ischemic stroke (Kasner et al) 1998;50:1857 central nervous system (Sriram et al) 1998;50:571
intravenous t-PA for acute ischemic stroke: therapeutic yield of stroke Chloride
code system (Zweifler et al) 1998;50:501 novel muscle chloride channel mutations in myotonia congenita with
neurologists’ attitudes regarding rt-PA for acute ischemic stroke various modes of inheritance including incomplete dominance and
(Villar—Cordova et al) 1998;50:1491 penetrance (Plassart—Schiess et al) 1998;50:1176 Con
noninvasive MRI evaluation of cerebral blood flow in cerebrovascular Chondroitin sulfate C
disease (Detre et al) 1998;50:633 steroid-responsive myopathy with deficient chondroitin sulfate C in
streptokinase in acute stroke: effect on reperfusion and recanalization skeletal muscle connective tissue (Al—Lozi et al) 1998;50:526
(Yasaka et al) 1998;50:626 Chorea Con
Ceroid lipofuscinoses chorea as form of presentation of human immunodeficiency virus-
bright light suppresses melatonin in blind patients with neuronal associated dementia complex (Pardo et al) 1998;50:568
ceroid lipofuscinoses (Haténen et al) 1998;50:1445 Chronic inflammatory demyelinating polyneuropathy
Cervical artery treatment of chronic inflammatory demyelinating polyneuropathy with Con
heritable connective tissue disorders in cervical artery dissections: interferon-« 2a (Gorson et al) 1998;50:84
prospective study (Schievink) 1998;50:1166 Chymotrypsin
Cervical radiculopathy apolipoprotein E and alpha-1 antichymotrypsin polymorphism
cervical radiculopathy and coexisting distal entrapment neuropathies genotyping in Alzheimer’s disease and in dementia with Lewy
(Morgan and Wilbourn) 1998;50:78 bodies (Lamb et al) 1998;50:388 Con
Charcot joint association between ACT polymorphism and Alzheimer’s disease
neuropathic shoulder arthropathy associated with syringomyelia (Kamboh et al) (Letter); (Egensperger et al) (Letter); (Miiller et al)
(Jones and Wolf) 1998;50:825 (Reply) 1998;50:574 Con
Charcot-Marie-Tooth disease Cigarette smoking
Charcot-Marie-Tooth disease and Noonan syndrome with giant genetic polymorphism of MAO-B modifies association of cigarette
proximal nerve hypertrophy (Silburn) 1998;50:1067 smoking and Parkinson’s disease (Checkoway et al) 1998;50:1458
1948 NEUROLOGY 50 June 1998
Clinical practice Copolymer-1
narrowing the evidence-practice gap (Holloway and Ringe!) (Editorial effect of copolymer-1 on serial gadolini h d magnetic
1998;50:319 resonance imaging in relapsing remitting multiple sclerosis
Clinical trials (Mancardi et al) 1998;50:1127
controlled trial of ketorolac in tension-type headache (Harden et al Corpus callosum
1998;50:507 agyria-pachygyria and agenesis of corpus callosum: autosomal
effectiveness of high-dose riboflavin in migraine prophylaxis (Schoenen recessive inheritance with neonatal death (Sztriha et al) 1998;50:
et al) 1998;50:466 1466
randomized, double-blind, placebo-controlled trial of depreny!l and Corrections
thioctic acid in human immunodeficiency virus-associated cognitive apolipoprotein E e4 allele is not associated with psychiatric symptoms
impairment (Dana Consortium on the Therapy of HIV Dementia and extrapyramidal symptoms in probable Alzheimer’s disease
and Related Cognitive Disorders) 1998;50:645 ane F z et al) (1997;49:794) 1998;50:566
Cocaine Central Nervous System Infectious Diseases and Therapy, editec, by
intracranial hemorrhage associated with cocaine abuse (Khellaf and Ro0 s (Booss) 1998;50:1943
Fénelon) (Letter); (Nolte) (Reply) 1998;50:1519 congenital myasthenic syndromes in two kinships with end-plate
Cognition disorders acetylcholine receptor and utrophin deficiency (Sieb et al) (1998;50:
epilepsy and mental retardation in subset of early onset 4q35- 54 1998; 50:838
fascioscapulohumeral muscular dystrophy (Funakoshi et al) 1998 icacy of pramipexole, a novel dopamine agonist, as monotherapy in
50:1791 i to moderate Parkinson’s disease (Shannon et al) (1997;49:724)
metrifonate treatment of cognitive deficits of Alzheim er’s disease 1998:50:838
(Cummings et al) 1998;50:1214 y of International Classification of Diseases in identifying
randomized, double-blind, placebo-controlled trial of depreny! and gnosis of ischemic cerebrovascular disease (Benesch et al) (1997;
thioctic acid in human immunodeficiency virus-associated cognitive 49:660) 1998;50:306
impairment (Dana Consortium on the Therapy of HIV Dementia large infarcts in the middle cerebral artery territory: etiology and
and Related Cognitive Disorders) 1998;50:645 yutcome patterns (Heinsius et al) 1998;50:1940
relation between MR abnormalities and patterns of cognitive Cortical degeneration
impairment in multiple sclerosis (Rovaeris et al) 1998;50:1601 progressive ventral posterior cortical degeneration presenting as alexia
Cognitive function r music and words (Beversdorf and Heilman) 1998;50:657
cognitive decline and education in mild dementia (Unverzagt et al Cortical development
1998;50:181 abnormal! cortical development and epileptogenesis at epilepsy surgery
cognitive function in nondemented older women who took estrogen la) 1998;50:8
after menopause (Jacobs et al) 1998;50:368 metabolic dysfunction in patients with cortical developmental
cognitive impairment and dementia in prisoners of war Abalan and 1 lal formations: proton magnetic resonance imaging study (Li et al)
Ellison) (Letter); (Sulway et al) (Reply) 1998;50:312 1998-50:755
cognitive screening examinations for silent cerebra! infarcts in sickle sublobal dysplasia: new malformation of cortical development
(DeBaun et al) 1998;50:1678 Barkovich and Peacock) 1998;50:1383
cognitive test performance among nondemented elderly African Cortical dysplasia
Americans and whites (Manly et al) 1998;50:1238 immunocytochemical study of three patients (Spreafico et al) 1998;50:
L-deprenyl in Alzheimer’s disease; cognitive and behavioral effects
(Freedman et al) 1998;50:660
Cortical infarction
do antiarthritic drugs decrease risk for cognitive decline? Prince et al
olated weakness of fingers in cortical infarction (Lee et al) 1998;50:
1998;50:374
drugs acting at glycine site on NMDA receptor as cognitive enhancers
Cc orticospinal tract
in patients with Alzheimer’s disease (Roesler et al) (Letter) 1998 decrea ed N-acetylaspartate in motor cortex and corticospinal tract in
50:1195
ALS (Rooney et al) 1998;50:1800
lack of relation between race and cognitive test performance in
Corticosteroids
Alzheimer’s disease (Carlson et al) 1998;50:1499 response to corticosteroid therapy in a patient with HTLV-I-associated
levodopa improves motor function without regis ig cognition in mild
tor neuron disease (Hanakawa et al) 1998;50:1188
nondemented Parkinson’s disease patients (Growden et al) 1998;50
Cc ranial aneurysms
1327
mult intracranial and systemic aneurysms associated with
metrifonate benefits cognitive, behavioral, and globa! function in
ile-onset arterial fibromuscular dysplasia (Lee et al) 1998;50:
Alzheimer’s disease patients (Morris et al) 1998;50:1222 R28
mid-life cardiovascular risk factors, apoE «4, and cognitive decline in
elderly male twins (Carmelli et al) 1998;50:1580 Cc rental hemorrhage
motor slowing precedes cognitive impairment in oldest ld (Camicioli racranial hemorrhage associated with idiopathic thrombocytopenic
et al) 1998;50:1496 yura: report of seven patients and meta-analysis (Lee and Kim)
sulcal variability in the Alzheimer’s brain correlated w th cognition 1998;50:1160
(Mega et al) 1998;50:145 Cranial nerves; see specific nerves
temporal lobe epilepsy in genius of natural history MRI volumetric Cranial stenosis
study of postmortem brain (Murai et al) 1998;50:1373 ntracranial steaosis in Chinese patients with acute stroke (Wong et
Computed tomography 1998;50:812
brain-behavior correlations in hemispatia! neglect using CT and Cranial vasculature
SPECT; The Sunnybrook Stroke Study (Le2 obovicch et al) 1998;50 Drogressive facial hemiatrophy: abnormality of intracranial
901 asculature (Woolfenden et al) 1998;50:1915
CT imaging in adults with neurofibromatosis-1: frequent asymptomatic Creutzfeldt-Jakob disease
plexiform lesions (Tonsgard et al) 1998;50:1755 Creutzfcidt-Jakob disease after blood product transfusion for donor
Conflicts of interest ith CJD (Patry et al) 1998;50:1872
American Academy of Neurology Policy on Conflicts of Interest (Ethics Creutzfeldt-Jakob disease in husband and wife (Brown et al) 1998;50:
and Humanities Subcommittee) (Position Statement) 1998;50:332 654
conflicts of interest in neurology (Bernat et al) (Editorial) 1998;50:327 CTG repeats
Congenital myasthenic syndromes lative stability of minimal CTG repeat expansion in large kindred
congenital myasthenic syndromes in kinships with endplate with myotonic dystrophy (Simmons et al) 1998;50:1501
acetylcholine receptor and utrophin deficiency (Sieb et al) 1998;50 Cysticercosis
54 albendazole therapy for neurocysticercosis (Ko and Chang) (Letter);
Connective tissue Garcia et al) (Reply) 1998;50:834
heritable connective tissue disorders in cervical artery dissections: Cytokines; see also specific cytokines
prospective study (Schievink) 1998;50:1166 anticyto ine antibodies in beta-interferon-treated patients (Palatucci)
steroid-responsive myopathy with deficient chondroitin sulfate C in Letter); (Sibley et al) (Letter); (Pachner) (Reply) 1998;50:1930
skeletal muscle connective tissue (Al—Lozi et al) 1998;50:526 yptic neuritis and cytokines related to MRI abnormalities and
Connexin oligoclonal bands (Kivisakk et al) 1998;50:217
X-linked Charcot-Marie-Tooth disease with connexin 32 mutations; in vivo effects of interferon beta-la on i PP essive cytokines in
clinical and electrophysiologic study (Birouk et al) 1998;50:1074 multiple sclerosis (Rudick et al) 1998;50:1294
Contraceptive drugs Cytomegalovirus
gabapentin does not interact with contraceptive regimen of diagnosis of cytomegalovirus encephalitis in patients with AIDS by
norethindrone acetate and ethiny! estradio! (Eldon et al) 1998;50 quantitation of cytomegalovirus genomes in cells of cerebrospinal
1146 fluid (Wildemann et al) 1998;50:693
June 1998 NEUROLOGY5 0 1949
D Diabetes mellitus
double-blind randomized trial of tramadol for the treatment of the
DATATOP study pain of diabetic neuropathy (Harati et al) (Expedited Publication)
alpha tocopherol in CSF of subjects taking high-dose vitamin E in 1998;50:1842
DATATOP study (Vatassery et al) 1998;50:1900 prospective quantitative study of sensory deficits after whole sural
Deaf/blind syndrome nerve biopsies in diabetic and nondiabetic patients: surgical
delayed diagnosis of Friedrich’s ataxia due to coexisting recessive deaf/ approach and role of collateral sprouting (Theriault et al) 1998;50:
blind syndrome (de Silva et al) 1998;50:1924 480
Deep vein thrombosis Dichloroacetate
pneumatic sequential compression reduces risk of deep vein effects of dichloroacetate in patients with MELAS (Saitoh et al) 1998;
thrombosis in stroke patients (Kamran et al) 1998;50:1683 50:531
Delirium Diencephalic compression
acute delirium after withdrawal of amantadine in Parkinson’s disease spontaneous intracranial hypotension resulting in stupor due to
(Factor et al) 1998;50:1456 diencephalic compression (Pleasure et al) 1998;50:1854
Delivery Disconnection syndromes
postpartum cerebral angiopathy with intracerebral hemorrhage in could pure alexia be due to disconnection syndrome? (Mark) (Letter);
patient receiving lisuride (Roh and Park) 1998;50:1152 (Benito—Leén) (Reply) 1998;50:835
Dementia; see also Alzheimer’s disease DNA
cognitive decline and education in mild dementia (Unverzagt et al) human herpesvirus 8 DNA in CNS lymphomas from patients with and
1998;50:181 without AIDS (Corboy et al) 1998;50:335
cognitive impairment and dementia in prisoners of war (Abalan and DNA, mitochondrial
Ellison) (Letter); (Sulway et al) (Reply) 1998;50:312 clinical manifestations of mitochondrial DNA depletion (Vu et al) 1998;
effect of education on dementia occurrence in Italian population with 50:1783
middle to high socioeconomic status (De Ronchi et al) 1998;50:1231 mitochondrial tRNA" gene mutation in patient with mitochondrial
epileptic pseudodementia (Tatum et al) 1998;50:1472 myopathy, lactic acidosis, and stroke-like episodes (de Coo et al)
familial aggregation in frontotemporal dementia (Stevens et al) 1998; 1998;50:293
50:1541 multiple mtDNA deletions features in autosomal dominant and
genotypes, phenotypes, and frontotemporal dementia (Bird) (Editorial) recessive diseases suggest distinct pathogeneses (Carrozzo et al)
1998;50:1526 1998;50:99
myoclonus epilepsy with ragged red fibers and multiple mtDNA
hereditary dysphasic disinhibition dementia (Lendon et al) 1998;50:
deletions (Blumenthal et al) 1998;50:524
1998;50:1546
Docetaxel
incidence and subtypes of dementia in southern Taiwan (Liu et al)
Lhermitte’s sign following chemotherapy with docetaxel (van den Bent
1998;50:1572
et al) 1998;50:563
postmenopausal estrogen use and Parkinson’s disease with and
without dementia (Marder et al) 1998;50:1141 DocuHemaelntth atCiaroen Financing Administration’s new examination Ec
SPECT study of German CADASIL family: phenotype with migraine documentation criteria: minimum auditing standards for neurologic
and progressive dementia (Mellies et al) 1998;50:1715 examination to be used by Medicare and other payors (Nuwer and
Dementia, analysis Sigsbee) 1998;50:497
object and action naming in Alzheimer’s disease and frontotemporal neurologic single system examination documentation requirements
dementia (Cappa et al) 1998;50:351 (Goldstein and Ringel) (Editorial) 1998;50:326
Dementia, epidemiology Dolichoectasia
dementia mortality in United States (Lanska) 1998;50:362 dolichoectasia of intracranial arteries in patients with first ischemic
prevalence of dementia in Chinese elderly in Hong Kong (Chiu et al) stroke: population-based study (Ince et al) 1998;50:1694
1998;50:1002 Donepezil
prevalence of dementia over age 100 (Thomassen et al) 1998;50:283 24-week, double-blind, placebo-controlled trial of donepezil in patients Ed
Dernentia, etiology with Alzheimer’s disease (Rogers et al) 1998;50:136
estimation of temporal probability of human immunodeficiency virus Dopa; see also Levodopa
dementia after risk stratification for HIV-infected persons (Qureshi dopa-responsive dystonia: some pieces of puzzle are still missing Ed
et al) 1998;50:392 (Nygaard and Wooten) (Editorial) 1998;50:853
Dementia, genetics gender-related penetrance and de novo GTP-cyclohydrolase I gene
apolipoprotein E and alpha-1 antichymotrypsin polymorphism mutations in dopa-responsive dystonia (Furukawa et al) 1998;50:
genotyping in Alzheimer’s disease and in dementia with Lewy 1015
bodies (Lamb et al) 1998;50:388 mood response to L-dopa infusion in early Parkinson’s disease (Maricle El
Dementia, HIV-associated et al) 1998;50:1890 El
chorea as form of presentation of human immunodeficiency virus- reduced lymphoblast neopterin detects GTP cyclohydrolase dysfunction
associated dementia complex (Pardo et al) 1998;50:568 in dopa-responsive dystonia (Bezin et al) 1998;50:1021
variable progression of HIV-associated dementia (Bouwman et al) striatal D2 receptors in symptomatic and asymptomatic carriers of
1998;50:1814 dopa-responsive dystonia measured with [''C]-raclopride and
Dementia, vascular positron-emission tomography (Kishore et al) 1998;50:1028
population study on blood-brain barrier function in 85-year-olds: tardive dyskinesia in dopa-responsive dystonia: reappraisal of
relation to Alzheimer’s disease and vascular dementia (Skoog et al) dopamine hypothesis of tardive dyskinesia (de la
1998;50:966 Feunte—Fernandez) 1998;50:1134
Demyelinating diseases Dopamine
procainamide-induced chronic inflammatory demyelinating olanzapine in treatment of dopaminomimetic psychosis in patients
polyradiculoneuropathy (Erdem et al) 1998;50:824 with Parkinson’s disease (Friedman) (Letter); (Wolters et al) El
treatment of chronic inflammatory demyelinating polyneuropathy with (Reply) 1998;50:1195
striatal uptake of dopamine reuptake ligand [''C]B-CFT is reduced in
interferon-a 2a (Gorson et al) 1998;50:84
Alzheimer’s disease assessed by positron emission tomography
Dentatorubral-pallidoluysian atrophy
(Rinne et al) 1998;50:152
brainstem and thalamic lesions in dentatorubral-pallidoluysian
Double-crush hypothesis
atrophy: MRI study (Tomiyasu et al) 1998;50:1887
cervical radiculopathy and coexisting distal entrapment neuropathies
sporadic cases of dentatorubral-pallidoluysian atrophy associated with (Morgan and Wilbourn) 1998;50:78
maternal transmission (Shimohata et al) 1998;50:282 Down syndrome
Department of Veterans Affairs earlier onset of Alzheimer’s disease in men with Down syndrome
change in Department of Veterans Affairs (Woodward) (Letter); (Booss) (Schupf et al) 1998;50:991
(Reply) 1998;50:1520 Drug therapy; see also specific drugs and drug types
Deprenyl anticytokine antibodies in beta-interferon-treated patients (Palatucci)
L-depreny! in Alzheimer’s disease; cognitive and behavioral effects (Letter); (Sibley et al) (Letter); (Pachner) (Reply) 1998;50:1930
(Freedman et al) 1998;50:660 fluoroquinolone antibiotics block neuromuscular transmission (Sieb) Er
randomized, double-blind, placebo-controlled trial of deprenyl and 1998;50:804
thioctic acid in human immunodeficiency virus-associated cognitive Dyskinesia
impairment (Dana Consortium on the Therapy of HIV Dementia amantadine as treatment for dyskinesias and motor fluctuations in
and Related Cognitive Disorders) 1998;50:645 Parkinson’s disease (Verhagen Metman et al) 1998;50:1323 Ex
Depression Dysphasia
frontal lobe hypometabolism and depression in Alzheimer’s disease hereditary dysphasic disinhibition dementia (Lendon et al) 1998;50:
(Hirono et al) 1998;50:380 1998;50:1546
1950 NEUROLOGY 50 June 1998
Dysplasia tumor necrosis factor-a, interleukin-18, and interleukin-6 in
sublobal dysplasia: new malformation of cortical development cerebrospinal fluid from children with prolonged febrile seizures
(Barkovich and Peacock) 1998;50:1383 compared with acute encephalitis/ phalopathy (Ichiyama et al)
Dystonia 1998;50:407
dopa-responsive dystonia: some pieces of puzzle are still missing Encephalomyelitis
(Nygaard and Wooten) (Editorial) 1998;50:853 meningoencephalomyelitis caused by herpes simplex virus-1 in patient
gender-related penetrance and de novo GTP-cyclohydrolase I gene with idiopathic T CD4+ lymphocytopenia (Tumbarello et al) 1998;
mutations in dopa-responsive dystonia (Furukawa et al) 1998;50 50:569
1015 Encephalopathy
long-term effect of botulinum toxin on impairment and functional furoxime-induced encephalopathy (Herishanu et al) 1998;50:1873
health in cervical dystonia (Brans et al) 1998;50:1461 ironic progressive leukoencephalopathy in adult celiac disease
novel mutation of GTP-cyclohydrolase | gene in patient with Beyenburg et al) 1998;50:820
hereditary progressive dystonia/dopa-responsive dystonia (Imaiso effects of dichloroacetate in patients with MELAS (Saitoh et al) 1998;
et al) 1998;50:517 50:531
reduced lymphoblast neopterin detects GTP cyclohydrolase dysfunction tumor necrosis factor-a, interleukin-18, and interleukin-6 in
in dopa-responsive dystonia (Bezin et al) 1998;50:1021 cerebrospina! fluid from children with prolonged febrile seizures
spurious familial dystonia (Koppel et al) 1998;50:1508 mmpared with acute encephalitis/encephalopathy (Ichiyama et al)
striatal D2 receptors in symptomatic and asymptomatic carriers of 1998;50:407
dopa-responsive dystonia measured with [''C|-raclopride and Endarterectomy
positron-emission tomography (Kishore et a!) 1998;50:1028 are carotid endarterectomy complication rates being monitored?
tardive dyskinesia in dopa-responsive dystonia: reappraisal of Chaturvedi and Femino) 1998;50:1927
dopamine hypothesis of tardive dyskinesia (de la
does the neurologist add value to the carotid endarterectomy patient?
Feunte—Fernandez) 1998;50:1134 Chaturvedi and Hachinski) (Views & Reviews) 1998;50:610
Dystrophy Entrapment neuropathies
loss of serotonin-containing neurons in raphe of patients with myotonic
ervical radiculopathy and coexisting distal entrapment neuropathies
dystrophy: quantitative immunohistochemica! study and relation to
Morgan and Wilbourn) 1998;50:78
hypersomnia (Ono et al) 1998;50:535
Enzyme Q10
new mitochondrial tRNA™* gene mutation in case with dystrophic
absorption, tolerability, and effects on mitochondrial activity of oral
muscle and exercise intolerance (Vissing et al 1998;50:1875
enzyme Q10 in parkinsonian patients (Shults) 1998;50:793
Epilepsy
E
arbamazepine responsive epileptic oral motor and oculomotor apraxia
Eating disorders aqvi et al) 1998;50:1475
‘gourmand syndrome’ (Cockrell) (Letter); (Regard and Landis) (Reply and mental retardation in subset of early onset 4q35-
1998;50:831 fascioscapulohumeral muscular dystrophy (Funakoshi et al) 1998;
Economics 50:1791
cost-effectiveness of tissue plasminogen activator for acute ischemic sy provoked by television and video games; safety of 100-Hz
stroke (Fagan et al) 1998;50:883 screens (Ricci et al) 1998;50:790
effect of education on dementia occurrence in Italian population with pileptic pseudodementia (Tatum et al) 1998;50:1472
middle to high socioeconomic status (De Rone hi et al) 1998;50:1231 epileptic skew deviation (Galimberti et al) 1998;50:1469
Health Care Financing Administration’s new examination subacute postictal aggression (Gerard et al) 1998;50:384
documentation criteria: minimum auditing standards for neurologi: Epilepsy, diagnosis
examination to be used by Medicare and oth er payors | Nuwer anc pilepsy diagnosis and localization in patients with antecedent
Sigsbee) 1998;50:497 hildhood febrile convulsions (Hamati—Haddad and Abou—Khalil)
use and cost of medical resources: what will we pay for neurologic 1998;50:917
health? (Gilliam and Wennberg) (Editorial) 1998;50:1528 Epilepsy, epidemiology
Edema
idiopathic intracranial hypertension and orthostatic edema may share Hesdorffer et al) 1998;50:735
common pathogenesis (Friedman and Streeten) 1998;50:1099 Epilepsy, etiology
Education subtle hippocampal malformation: importance in febrile seizures and
cognitive decline and education in mild dementia (1 nverzagt et al ievelopment of epilepsy (Sloviter and Pedley) (Editorial) 1998;50:
1998;50:181 846
effect of education on dementia occurrence in Italic an population with Epilepsy, genetics
middle to high socioeconomic status (De Ronchi et al) 1998;50:1231 vidence for genetic predisposition for status epilepticus (Corey et al)
Elderly persons; see Aged 1998;50:558
Electrocerebral activity 9p and epilepsy (Scalise et al) (Letter); (Stern) (Reply) 1998;
electrocerebral inactivity associated with obstructiv e sleep apnea (Ko
(Letter); (Connelly et al) (Reply) 1998;50:1934 Epilepey, leoeilestion
Electroencephalography epilepsy diagnosis and localization in patients with antecedent
EEG findings in frontal lobe epilepsies (Bautista et al) 1998;50:1765 childhood febrile convulsions (Hamati-Haddad and Abou-Khalil)
EEG findings in patients with hippocampal atrophy (Van Paesschen et 1998:50:917
al) (Letter); (King et al) (Reply) 1998;50:1515
Epilepsy, myoclonus
EEG in anti-epileptic drug withdrawal! in partia! epilepsies (Chabolla
myoclonus epilepsy with ragged red fibers and multiple mtDNA
(Letter); (Tinuper et al) (Reply) 1998;50:1518
deletions (Blumenthal et al) 1998;50:524
transient autobiographic aranesia etiology (Venneri and Caffarra)
Epilepsy, partial
1998;50:186
EEG in antiepileptic drug withdrawal in partial epilepsies (Chabolla)
Electrophysiologic studies
Charcot-Marie-Tooth disease type 1A with 17p duplication in infancy Letter); (Tinuper et al) (Reply) 1998;50:1518
and early childhood: longitudinal! clinical and electrophysiologic Epilepsy, surgery
study (Garcia et al) 1998;50:1061 abnormal cortical development and epileptogenesis at epilepsy surgery
electrophysiologic aids in distinguishing organic from psychogenic Sutula) 1998;50:8
tumor (McAuley et al) 1998;50:1882 Rplepay; temporal lobe
electrophysiologic findings in multifocal motor neuropathy (Résler) absence of normal activation of left anterior fusiform gyrus during
(Letter) (Katz et al) (Reply) 1998;50:1936 naming in'left temporal lobe epilepsy (Henry et al) 1998;50:787
X-linked Charcot-Marie-Tooth disease with connexin 32 mutations; clinical seizure lateralization in mesial temporal lobe epilepsy;
clinical and electrophysiologic study (Birouk et al) 1998;50:1074 differences between patients with unitemporal and bitemporal
Electroretinography interictal spikes (Series et al) 1998;50:742
vigabatrin-associated retinal cone system dysfunction; familial temporal lobe epilepsy (Cendes et al) 1998;50:554
electroretinogram and ophthalmologic findings (Krauss et al) 1998; functional MRI lateralization of memory in temporal lobe epilepsy
50:614 Detre et al) 1998;50:926
Embolism late-onset temporal lobe epilepsy and dilatation of hippocampal sulcus
efficacy of prourokinase in embolic stroke model evaluated by by enlarged Virchow-Robin space (Bastos et al) 1998;50:784
diffusion-perfusion magnetic resonance imaging ‘Takano et al) nocturnal temporal lobe epilepsy (Bernasconi et al) 1998;50:1772
1998;50:870 recurrent seizures may cause hippocampal damage in temporal lobe
Encephalitis epilepsy (Kalvidinen et al) 1998;50:1377
diagnosis of cytomegalovirus encephalitis in patients with AIDS by temporal lobe developmental malformations and epilepsy; dual
quantitation of cytomegalovirus genomes in cells of cerebrospinal pathology and bilateral hippocampal abnormalities (Ho et al) 1998;
fluid (Wildemann et al) 1998;50:693 50:748
June 1998 NEUROLOGY5 0 1951
temporal lobe epilepsy in genius of natural history; MRI volumetric Fibromuscular dysplasia
study of postmortem brain (Murai et al) 1998;50:1373 multiple intracranial and systemic aneurysms associated with
Epilepsy, therapy infantile-onset arterial fibromuscular dysplasia (Lee et al) 1998;50:
EEG in antiepileptic drug withdrawal in partial epilepsies (Chabolla) 828
(Letter); (Tinuper et al) (Reply) 1998;50:1518 Finance; see Economics
potential mechanism of slowed pubertal maturation after chronic FK506
administration of of sodium valproic acid (Snyder and Badura) cerebral vasculitis during FK506 treatment in liver transplant patient
1998;50:922 (Pizzolato et al) 1998;50:1154
randomized prospective study of early discontinuation of antiepileptic Fluoroquinolones
drugs in children with epilepsy (Peters et al) 1998;50:724 fluoroquinolone antibiotics block neuromuscular transmission (Sieb)
testosterone versus testosterone and testolactone in treating 1998;50:804
reproductive and sexual dysfunction in men with epilepsy and Focal neurologic events
hypogonadism (Herzog et al) 1998;50:782 role of anticardiolipin antibodies in young persons with migraine and
Epstein-Barr virus transient focal neurologic events (Tietjen et al) 1998;50:1433
calcification in basal ganglia with chronic active Epstein-Barr virus Foramen ovale, patent
infection (Morita et al) 1998;50:1485 femoral injection of echocontrast medium may increase sensitivity of
Erve virus testing for patient foramen ovale (Hamann et al) 1998;50:1423
thunderclap headache caused by Erve virus? (Treib et al) 1998;50:509 Fragile X syndrome
Erythrocytes decreased cerebellar posterior vermis size in fragile X syndrome
increased very long-chain fatty acids in erythrocyte membranes in correlated with neurocognitive performance (Mostofsky et al) 1998;
patients with acerulopl ia (Miyajima et al) 1998;50:130 50:121 Glo
Estradiol Frontal lobes
gabapentin does not interact with contraceptive regimen of dissociation between verbal and autonomic measures of memory
norethindrone acetate and ethiny! estradiol (Eldon et al) 1998;50: following frontal lobe damage (Rapcsak et al) 1998;50:1259
1146 familial aggregation in frontotemporal dementia (Stevens et al) 1998;
Estrogen 50:1541
cognitive function in nondemented older women who took estrogen frontal lobe hypometabolism and depression in Alzheimer’s disease
after menopause (Jacobs et al) 1998;50:368 (Hirono et al) 1998;50:380 Glu
estrogen-replacement therapy and Alzheimer’s disease in Italian frontal lobe volume in patients with Huntington’s disease (Aylward et
Longitudinal Study on Aging (Baldereschi et al) 1998;50:996 al) 1998;50:252
postmenopausal estrogen use and Parkinson’s disease with and language comprehension and regional cerebral defects in Glu
without dementia (Marder et al) 1998;50:1141 frontotemporal degeneration and Alzheimer’s disease (Grossman et
Ethics al) 1998;50:157
assisted suicide, euthanasia, and the neurologist (Ethics and Fusiform gyrus
Humanities Subcommittee) (Position Statement) 1998;50:596 absence of normal activation of left anterior fusiform gyrus during GM
ethical issues in clinical research in neurology: advancing knowledge naming in left temporal lobe epilepsy (Henry et al) 1998;50:787
and protecting human research subjects (Ethics and Humanities
Subcommittee) (Position Statement) 1998;50:592 G
Euthanasia Gabapentin Gov
assisted suicide, euthanasia, and the neurologist (Ethics and
alternative uses of lamotrigine and gabapentin in treatment of
Humanities Subcommittee) (Position Statement) 1998;50:596
trigeminal neuralgia (Carrazana and Schachter) (Letter); (Leandri
Evoked potentials, motor and Lunardi) (Reply) 1998;50:1192 Gu:
phenytoin does not influence postexercise facilitation of motor evoked
gabapentin does not interact with contraceptive regimen of
potentials (Samii et al) 1998;50:291
norethindrone acetate and ethinyl] estradiol (Eldon et al) 1998;50:
Evoked potentials, somatosensory
1146
effects of voluntary contraction on tibial nerve somatosensory evoked
Gadolinium
potentials: gating of specific cortical responses (Tinassi et al) 1998;
magnetization transfer ratios in multiple sclerosis lesions enhancing
50:1655
after different doses of gadolinium (Filippe et al) 1998;50:1289
Exercise
Gamma Knife therapy
decay of postexercise augmentation in Lambert-Eaton myasthenic
jaw clenching following Gamma Knife treatment for trigeminal
syndrome; effect of cooling (Maddison et al) 1998;50:1083 neuralgia (Hochman) (Letter); (Young) (Reply) 1998;50:1193 Gui
effects of aerobic training in patients with mitochondrial myopathies
Gastroenteritis
(Taivassalo et al) 1998;50:1055
CSF levels of carnitine in children with meningitis, neurological
new mitochondrial tRNAM* gene mutation in case with dystrophic
disorders, acute gastroenteritis and seizures (Shinawi et al) 1998;
muscle and exercise intolerance (Vissing et al) 1998;50:1875
50:1869
why do patients with McArdle’s disease have decreased exercise
Gender; see also Females
capacity? (Ruff) (Editorial) 1998;50:6
Extinction gender-related penetrance and de novo GTP-cyclohydrolase I gene =
mutations in dopa-responsive dystonia (Furukawa et al) 1998;50:
tactile salience influences extinction (Aglioti et al) 1998;50:1010
1015
treatment outcome of tacrine therapy depends on apolipoprotein He:
F genotype and gender of subjects with Alzheimer’s disease (Farlow)
1998;50:669
Fabry disease Genetics
quantitative analysis of cerebral vasculopathy in Fabry disease familial typical migraine: linkage to chromosome 19p13 and evidence
(Crutchfield et al) 1998;50:1746 for genetic heterogeneity (Nyholt et al) 1998;50:1428
Facial hemiatrophy genetic polymorphism of MAO-B modifies association of cigarette
progressive facial hemiatrophy: abnormality of intracranial smoking and Parkinson’s disease (Checkoway et al) 1998;50:1458
vasculature (Woolfenden et al) 1998;50:1915 novel muscle chloride channel mutations in myotonia congenita with
Facial paresis various modes of inheritance including incomplete dominance and
isolated voluntary facial paresis due to pontine ischemia (Urban et al) penetrance (Plassart—Schiess et al) 1998;50:1176
1998;50:1860 Gene transfer
Facial weakness suppression of human glioma growth by adenovirus-mediated Rb gene
facial weakness in hereditary inclusion body myopathies (Argov et al) transfer (Fueyo et al) 1998;50:1307
1998;50:1925 Genotype
Farming apolipoprotein E and alpha-1 antichymotrypsin polymorphism
risk of Parkinson’s disease with exposure to pesticides, farming, well genotyping in Alzheimer’s disease and in dementia with Lewy
water, and rural living (Gorell et al) 1998;50:1346 bodies (Lamb et al) 1998;50:388
Fatty acids apolipoprotein E genotype influences cognitive ‘phenotype’ in patients
increased very long-chain fatty acids iin erythrocyte membranes in with Alzheimer’s disease but not in healthy control subjects (Smith
patients with acerulop (Miyajima et al) 1998;50:130 et al) 1998;50:355
Females; see also Gender CSF tau is related to apolipoprotein E genotype in early Alzheimer’s
effects of weight loss on course of idiopathic intracranial hypertension disease (Tapiola et al) 1998;50:169
in women (Kupersmith et al) 1998;50:1094 genotypes, phenotypes, and frontotemporal dementia (Bird) (Editorial) He
postpartum cerebral angiopathy with intracerebral hemorrhage in 1998;50:1526
patient receiving lisuride (Roh and Park) 1998;50:1152 treatment outcome of tacrine therapy depends on apolipoprotein
X-linked female band heterotopia-male lissencephaly syndrome (Berg genotype and gender of subjects with Alzheimer’s disease (Farlow)
et al) 1998;50:1143 1998;50:669
1952 NEUROLOGY5 0 June 1998